Your browser doesn't support javascript.
loading
Corrigendum: The efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma.
Zeng, Zhimin; Qian, Xiaoying; Liu, Fanrong; Wang, Yong; Yuan, Yong; Fang, Chen; Zhang, Xinwei; Yuan, Shangkun; Chen, Renfang; Yu, Biao; Wang, Tong; Yin, Yan; Li, Yong; Liu, Anwen.
Afiliación
  • Zeng Z; Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Qian X; Jiangxi Key Laboratory of Clinical Translational Cancer Research, Nanchang, Jiangxi, China.
  • Liu F; Radiation Induced Heart Damage Institute of Nanchang University, Nanchang, Jiangxi, China.
  • Wang Y; Department of Medical Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Yuan Y; Medical Innovation Center, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Fang C; Department of Pathology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Zhang X; Department of Medical Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Yuan S; Medical Innovation Center, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Chen R; Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Yu B; Department of Medical Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Wang T; Medical Innovation Center, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Yin Y; Department of Medical Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Li Y; Medical Innovation Center, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Liu A; Department of Medical Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Front Immunol ; 14: 1269596, 2023.
Article en En | MEDLINE | ID: mdl-37744366
[This corrects the article DOI: 10.3389/fimmu.2022.956982.].
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza